ANNOUNCEMENT

These 11 companies will be featured in the MedCity ENGAGE Innovation Showcase June 5-6 in Washington, D.C.

Topic: Merck

Glaxo, Merck in plan to send vaccine to Africa

Glaxo, Merck in plan to send vaccine to Africa

May 10, 2013 4:30 am by | 0 Comments

Multinational drug companies, like other businesses, see Africa as an emerging market with tremendous opportunities and challenges, and that was a backdrop to Thursday's announcements of two programs designed to ... Read more
Merck, GSK cut price of cervical cancer shots for poor countries

Merck, GSK cut price of cervical cancer shots for poor countries

May 9, 2013 7:17 am by | 0 Comments

LONDON (Reuters) - Drugmakers Merck and GlaxoSmithKline have cut the price of cervical cancer shots in a deal that will deliver them to poor countries for less than $5 a ... Read more
FDA approves Merck combination cholesterol lowering pill

FDA approves Merck combination cholesterol lowering pill

May 3, 2013 3:44 pm by | 0 Comments

(Reuters) - The U.S. Food and Drug Administration approved a Merck & Co cholesterol lowering pill that combines a generic version of Pfizer Inc's Lipitor with its own Zetia, Merck ... Read more
Merck, Pfizer to jointly develop diabetes drug

Merck, Pfizer to jointly develop diabetes drug

April 29, 2013 8:01 am by | 0 Comments

(Reuters) - Drugmakers Pfizer Inc and Merck & Co Inc said they would jointly develop Pfizer's experimental type 2 diabetes drug, ertugliflozin, and expect late-stage trials to start later in ... Read more
Merck melanoma drug wins ‘breakthrough’ designation

Merck melanoma drug wins ‘breakthrough’ designation

April 24, 2013 11:37 am by | 0 Comments

April 24 (Reuters) - U.S. regulators have granted Merck & Co's experimental treatment for advanced melanoma a "breakthrough therapy" designation, which could speed development and regulatory review of the product.The ... Read more
Experimental sleep drug may cause fewer side effects: Merck study

Experimental sleep drug may cause fewer side effects: Merck study

April 3, 2013 3:12 pm by | 0 Comments

CHICAGO (Reuters) - A study in rats and monkeys suggests an experimental Merck & Co sleep drug may help induce sleep without causing the memory loss and attention problems sometimes ... Read more
Merck unit sues India’s Glenmark over diabetes drug

Merck unit sues India’s Glenmark over diabetes drug

April 2, 2013 11:13 am by | 0 Comments

MUMBAI (Reuters) - A unit of U.S. drugmaker Merck & Co sued India's Glenmark Pharmaceuticals on Tuesday for infringing its patent on two diabetes drugs.The action comes a day after ... Read more
More FDA review for Merck post-anesthesia drug

More FDA review for Merck post-anesthesia drug

March 16, 2013 6:56 am by | 0 Comments

Merck & Co. said Friday that a drug designed to help patients coming out of anesthesia after surgery will require three more months of review by the U.S. Food and ... Read more
Merck Vytorin study to continue after panel review

Merck Vytorin study to continue after panel review

March 12, 2013 8:11 am by | 0 Comments

(Reuters) - Pharmaceutical company Merck & Co Inc said on Tuesday an independent monitoring board had allowed it to continue with a large trial assessing the safety and effectiveness of ... Read more
Merck names Roger M. Perlmutter, M.D., Ph.D., president of Merck Research Labs

Merck names Roger M. Perlmutter, M.D., Ph.D., president of Merck Research Labs

March 7, 2013 7:32 am by | 0 Comments

Merck, known as MSD outside the United States and Canada, today announced the appointment of Roger M. Perlmutter, M.D., Ph.D., as executive vice president and president of Merck Research Laboratories ... Read more
Diabetes drugs tied to pancreatitis: study

Diabetes drugs tied to pancreatitis: study

February 28, 2013 4:05 pm by | 1 Comments

NEW YORK (Reuters Health) - People who take a certain type of diabetes drug to lower blood sugar levels may be at an increased risk of developing an inflamed pancreas, ... Read more

Merck KGaA brain tumor drug fails clinical trial

Merck KGaA brain tumor drug fails clinical trial

February 25, 2013 4:33 am by | 0 Comments

FRANKFURT (Reuters) - Merck KGaA's Cilengitide, an experimental drug to treat an aggressive type of brain tumor, has failed a large-scale clinical trial, dealing a blow to the German drugmaker's ... Read more
Merck resolves securities class-action suit related to ENHANCE, to record $493M charge

Merck resolves securities class-action suit related to ENHANCE, to record $493M charge

February 14, 2013 8:01 am by | 0 Comments

Merck (NYSE: MRK) known as MSD outside the United States and Canada, announced today that it has reached an agreement in principle with plaintiffs to resolve two federal securities ... Read more

Appeals court upholds patent on Merck’s Vytorin

Appeals court upholds patent on Merck’s Vytorin

February 7, 2013 12:28 pm by | 0 Comments

WASHINGTON (Reuters) - The patent on Merck & Co's cholesterol fighters Zetia and Vytorin, two of the drugmaker's biggest products, is valid, a U.S. appeals court ruled on Thursday.Vytorin combines ... Read more
Merck hit with $285,000 verdict in Fosamax trial

Merck hit with $285,000 verdict in Fosamax trial

February 5, 2013 3:26 pm by | 0 Comments

NEW YORK, Feb 5 (Reuters) - A federal jury on Tuesday ordered Merck & Co Inc to pay $285,000 in a lawsuit over the risks of its osteoporosis drug Fosamax, ... Read more